Business
AstraZeneca US COVID-19 vaccine trial may resume as soon as this week – Sydney Morning Herald
The pharma giant’s coronavirus vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed…
In a research and development briefing held for CSL investors on Tuesday, the company’s chief scientific officer Dr Andrew Nash said preparations to produce both vaccines were moving along well and production of the AstraZeneca product could start early next year.
He said the AstraZeneca/Oxford and University of Queensland projects used different approaches, with UQ’s being a more “classical” vaccine model while AstraZeneca’s was a newer approach, and it was a positive that both projects could be…
-
Noosa News24 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
General20 hours agoFederal government funding extends cohealth GP services until July 2026
-
Noosa News18 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
Business21 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend